Regulation of Follicular Helper T cell Differentiation and Vaccination by IL3
IL3 对滤泡辅助 T 细胞分化和疫苗接种的调节
基本信息
- 批准号:8853812
- 负责人:
- 金额:$ 7.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntibody ResponseAntigensAutoantibodiesAutoimmune DiseasesB-LymphocytesBCL6 geneBLR1 geneCD4 Positive T LymphocytesCell Differentiation processCellsCommunicable DiseasesDevelopmentDevelopmental ProcessGene TargetingHelper-Inducer T-LymphocyteIL3 geneImmune responseInterleukin-3Knockout MiceLeadModelingPathway interactionsPhenotypePlayProductionReactionRegulationRegulatory PathwayRoleStructure of germinal center of lymph nodeT cell differentiationT-LymphocyteTestingTranscription Repressor/CorepressorVaccinationchemokine receptorcytokinefightingin vivoinsightmouse modelnovelnovel strategiespublic health relevanceresearch studyvaccine development
项目摘要
DESCRIPTION (provided by applicant): T helper cells are critical for the proper function of the immune response and are essential for helping B cells make antibody. Follicular helper T (TFH) cells are a specialized subset of CD4+ T helper cells whose role is to help B cells produce high affinity antigen-specific antibody, and to promote the germinal center reaction. In the absence of TFH cells, germinal centers and secondary antibody responses cannot develop. However, excessive development of TFH cells is correlated with autoimmune disease. TFH cells are localized to germinal centers within B cell follicles due to their expression of the chemokine receptor CXCR5, and are further characterized by high expression of the transcription repressor BCL6 and the B cell stimulatory cytokine IL-21. Recent studies have shown that BCL6 is the master transcriptional regulator for TFH cells: forced BCL6 expression induces a TFH phenotype in T cells, and TFH cells cannot develop in the absence of BCL6. However, the mechanism for how BCL6 promotes the TFH phenotype is incompletely understood. Using a new BCL6 conditional knockout (cKO) mouse model, we have recently identified novel gene targets of BCL6 in CD4 T cells that are likely to play a role in TFH cell differentiation. In this proposal, we will seek to better define the role of a specific BCL6 target gene, IL-3. Our general hypothesis is that the novel BCL6 target gene IL-3 inhibits TFH function and that blocking IL-3 will increase the antibody response. This hypothesis will be tested in the proposal that follows. INNOVATION: We have identified a previously unknown regulatory pathway for how BCL6 controls TFH cell differentiation and will test this pathway functionally. We will investigate a novel strategy for increasing the efficacy of vaccination for the production of Ab. IMPACT: This study will provide insights into the unique developmental process of TFH cells, and will lead to the delineation of a new regulatory pathway that can be targeted to promote or inhibit TFH function. These experiments will provide information that is critical for understanding the development of the antibody response to fight infectious disease. These studies should aid in the development of vaccines that target TFH cells, and will also impact studies on autoantibody production.
描述(由申请人提供):T辅助细胞对免疫反应的正常功能至关重要,也是帮助B细胞制造抗体的关键。滤泡辅助T细胞(TFH)是CD4+T辅助细胞的一个特殊亚群,其作用是帮助B细胞产生高亲和力的抗原特异性抗体,并促进生发中心反应。在没有TFH细胞的情况下,生发中心和二次抗体反应不能形成。然而,TFH细胞的过度发育与自身免疫性疾病有关。由于趋化因子受体CXCR5的表达,TFH细胞定位于B细胞滤泡内的生发中心,并进一步具有转录抑制因子BCL6和B细胞刺激因子IL-21的高表达。最近的研究表明,BCL6是TFH细胞的主要转录调控因子:强迫表达BCL6会诱导T细胞产生TFH表型,而TFH细胞在没有BCL6的情况下无法发育。然而,BCL6如何促进TFH表型的机制还不完全清楚。利用一种新的BCL6条件性基因敲除(CKO)小鼠模型,我们最近在CD4T细胞中发现了BCL6的新基因靶点,这些靶点可能在TFH细胞分化中发挥作用。在这项提案中,我们将寻求更好地定义特定的BCL6靶基因IL-3的作用。我们的一般假设是,新的BCL6靶基因IL-3抑制TFH功能,阻断IL-3将增强抗体反应。这一假设将在接下来的提案中得到检验。创新:我们已经确定了BCL6如何控制TFH细胞分化的先前未知的调控途径,并将从功能上测试这一途径。我们将研究一种新的策略,以提高疫苗接种的效力,以生产抗体。影响:这项研究将为TFH细胞独特的发育过程提供洞察力,并将导致描绘一条新的调控途径,可以有针对性地促进或抑制TFH功能。这些实验将提供对理解抗体反应的发展以对抗传染病至关重要的信息。这些研究应该有助于针对TFH细胞的疫苗的开发,也将影响对自身抗体产生的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander L Dent其他文献
Lipids-Я-Us: peroxisome generation of iNKT ligands
脂质-我-我们:iNKT 配体的过氧化物酶体生成
- DOI:
10.1038/ni.2288 - 发表时间:
2012-04-18 - 期刊:
- 影响因子:27.600
- 作者:
Randy R Brutkiewicz;Alexander L Dent - 通讯作者:
Alexander L Dent
Alexander L Dent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander L Dent', 18)}}的其他基金
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 7.8万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 7.8万 - 项目类别:
The control of allergic immune responses by follicular regulatory T cells
滤泡调节性 T 细胞对过敏性免疫反应的控制
- 批准号:
10165474 - 财政年份:2017
- 资助金额:
$ 7.8万 - 项目类别:
The Role of Follicular Helper T Cells in HIV Prime Boost Vaccination
滤泡辅助 T 细胞在 HIV 加强疫苗接种中的作用
- 批准号:
8875819 - 财政年份:2014
- 资助金额:
$ 7.8万 - 项目类别:
Regulation of Follicular Helper T cell Differentiation and Vaccination by IL3
IL3 对滤泡辅助 T 细胞分化和疫苗接种的调节
- 批准号:
8681872 - 财政年份:2014
- 资助金额:
$ 7.8万 - 项目类别:
Control of airway inflammation and Th2 differentiation by microRNA 21
microRNA 控制气道炎症和 Th2 分化 21
- 批准号:
8434965 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Development of follicular helper T cell deficient mice
滤泡辅助性T细胞缺陷小鼠的发育
- 批准号:
8289751 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Development of follicular helper T cell deficient mice
滤泡辅助性T细胞缺陷小鼠的发育
- 批准号:
8522152 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Control of autoimmunity by follicular helper T cells and BCL6
滤泡辅助 T 细胞和 BCL6 控制自身免疫
- 批准号:
8072744 - 财政年份:2010
- 资助金额:
$ 7.8万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别: